Preclinical services in Neurology, CNS and Behavioral pharmacology

BRAINXPLORE team provides its unique know‑how and innovative models to help you bridge the translational gap in CNS research. We support you to accelerate and secure your pipeline in the evaluation of drug candidates, lead compounds and medical devices. Over 35 years of experience serving an international clientele.

• Our in vitro offer: From hit-to-lead steps to lead characterization in complex cellular systems, our platforms enable you to screen and identify neuroprotective, antiaggregating, and thrombolytic candidate compounds.

• In vivo offer: robust and reproducible preclinical neurology services, supported by a comprehensive portfolio of gold‑standard in vivo models (Alzheimer, Parkinson, …). Multi‑scale approaches ranging from molecular biology to behavior.

• Robust, high-quality, and repeatable results: bioanalytical services (ELISA, WB, multiplexed assays, IHC) and high‑performance imaging (MRI, HCS).